BOPCF BioPharma Credit PLC

USD 0.89 0.00 0
Icon

BioPharma Credit PLC (BOPCF) Stock Analysis and Price Targets

COMMON STOCK | Other | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.89

0.00 (0.00)%

USD 1.00B

100.00

N/A

N/A

Icon

BOPCF

BioPharma Credit PLC (USD)
COMMON STOCK | OTC
USD 0.89
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.00B

N/A

USD 0.89

BioPharma Credit PLC (BOPCF) Stock Forecast

N/A

Based on the BioPharma Credit PLC stock forecast from 0 analysts, the average analyst target price for BioPharma Credit PLC is not available over the next 12 months. BioPharma Credit PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BioPharma Credit PLC is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, BioPharma Credit PLC’s stock price was USD 0.89. BioPharma Credit PLC’s stock price has changed by +0.00% over the past week, -3.26% over the past month and -4.81% over the last year.

No recent analyst target price found for BioPharma Credit PLC
No recent average analyst rating found for BioPharma Credit PLC

Company Overview BioPharma Credit PLC

BioPharma Credit PLC, an investment trust company, invests in interest-bearing debt assets secured by royalties or other cash flows derived from royalties or sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom....Read More

N/A

N/A

0

N/A

USD

USA

Adjusted Closing Price for BioPharma Credit PLC (BOPCF)

Loading...

Unadjusted Closing Price for BioPharma Credit PLC (BOPCF)

Loading...

Share Trading Volume for BioPharma Credit PLC Shares

Loading...

Compare Performance of BioPharma Credit PLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BOPCF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BioPharma Credit PLC (Sector: Other )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DISPF
Disco Corporation -0.70 (-0.19%) USD3,369.71B 18.60 -488.90

ETFs Containing BOPCF

Symbol Name BOPCF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About BioPharma Credit PLC (BOPCF) Stock

Stock Target Advisor's fundamental analysis for BioPharma Credit PLC's stock is Bearish.

Unfortunately we do not have enough data on BOPCF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BOPCF's stock to indicate what its average analyst target is.

BOPCF stock's Price/Earning ratio is 32.29. Our analysis grades BOPCF stock's Price / Earning ratio at F. This means that BOPCF stock's Price/Earning ratio is above 80% of the stocks in the Other sector in the OTC exchange. Based on this BOPCF may be a overvalued for its sector.

The last closing price of BOPCF's stock was USD 0.89.

The most recent market capitalization for BOPCF is USD 1.00B.

Unfortunately we do not have enough analyst data on BOPCF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains BioPharma Credit PLC's stock.

As per our most recent records BioPharma Credit PLC has 0 Employees.

Sorry we do not have any infomation available on BioPharma Credit PLC's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...